SlideShare uma empresa Scribd logo
1 de 3
Baixar para ler offline
GlycoMar Limited - Product Pipeline Review - 2014
GlycoMar Limited - Product Pipeline Review - 2014
Summary
Global Markets Directs, GlycoMar Limited - Product Pipeline Review - 2014, provides an overview of the GlycoMar Limiteds pharmaceutical research and
development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of GlycoMar Limiteds, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest
updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides brief overview of GlycoMar Limited including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of GlycoMar Limiteds human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major
milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the GlycoMar Limiteds pipeline products
Reasons to buy
- Evaluate GlycoMar Limiteds strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of GlycoMar Limited in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the GlycoMar Limiteds R&D portfolio and develop key strategic initiatives to reinforce pipeline in those
areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of GlycoMar Limited and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of GlycoMar Limited
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand
business potential and scope
- Explore the dormant and discontinued projects of GlycoMar Limited and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 4
glycomar Limited Snapshot 5
glycomar Limited Overview 5
key Information 5
key Facts 5
glycomar Limited - Research And Development Overview 6
key Therapeutic Areas 6
glycomar Limited - Pipeline Review 9
pipeline Products By Stage Of Development 9
pipeline Products - Monotherapy 10
pipeline Products - Partnered Products 11
partnered Products/combination Treatment Modalities 12
GlycoMar Limited - Product Pipeline Review - 2014
glycomar Limited - Pipeline Products Glance 13
glycomar Limited - Early Stage Pipeline Products 13
preclinical Products/combination Treatment Modalities 13
discovery Products/combination Treatment Modalities 14
glycomar Limited - Drug Profiles 15
gly-145 15
product Description 15
mechanism Of Action 15
r&d Progress 15
gly-2028 16
product Description 16
mechanism Of Action 16
r&d Progress 16
gly-079 17
product Description 17
mechanism Of Action 17
r&d Progress 17
gly-198 18
product Description 18
mechanism Of Action 18
r&d Progress 18
glyk-5006 19
product Description 19
mechanism Of Action 19
r&d Progress 19
inflammatory Bowel Disease Program 20
product Description 20
mechanism Of Action 20
r&d Progress 20
glycomar Limited - Pipeline Analysis 21
glycomar Limited - Pipeline Products By Target 21
glycomar Limited - Pipeline Products By Route Of Administration 22
glycomar Limited - Pipeline Products By Molecule Type 23
glycomar Limited - Pipeline Products By Mechanism Of Action 24
glycomar Limited - Locations And Subsidiaries 25
head Office 25
appendix 26
methodology 26
coverage 26
secondary Research 26
primary Research 26
expert Panel Validation 26
contact Us 27
disclaimer 27
list Of Tables
glycomar Limited, Key Information 5
glycomar Limited, Key Facts 5
glycomar Limited - Pipeline By Indication, 2014 8
glycomar Limited - Pipeline By Stage Of Development, 2014 9
glycomar Limited - Monotherapy Products In Pipeline, 2014 10
glycomar Limited - Partnered Products In Pipeline, 2014 11
glycomar Limited - Partnered Products/ Combination Treatment Modalities, 2014 12
glycomar Limited - Preclinical, 2014 13
glycomar Limited - Discovery, 2014 14
glycomar Limited - Pipeline By Target, 2014 21
glycomar Limited - Pipeline By Route Of Administration, 2014 22
glycomar Limited - Pipeline By Molecule Type, 2014 23
glycomar Limited - Pipeline Products By Mechanism Of Action, 2014 24
list Of Figures
glycomar Limited - Pipeline By Top 10 Indication, 2014 7
glycomar Limited - Pipeline By Stage Of Development, 2014 9
glycomar Limited - Monotherapy Products In Pipeline, 2014 10
glycomar Limited - Pipeline By Top 10 Route Of Administration, 2014 22
glycomar Limited - Pipeline By Top 10 Molecule Type, 2014 23
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
GlycoMar Limited - Product Pipeline Review - 2014
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
GlycoMar Limited - Product Pipeline Review - 2014

Mais conteúdo relacionado

Mais de QYResearchReports

State tourism us - august 2013
State tourism   us - august 2013State tourism   us - august 2013
State tourism us - august 2013QYResearchReports
 
ResearchMoz - Polymerase chain reaction (pcr) in medical application an analy...
ResearchMoz - Polymerase chain reaction (pcr) in medical application an analy...ResearchMoz - Polymerase chain reaction (pcr) in medical application an analy...
ResearchMoz - Polymerase chain reaction (pcr) in medical application an analy...QYResearchReports
 
Supermarkets and hypermarkets china - june 2013(1)
Supermarkets and hypermarkets   china - june 2013(1)Supermarkets and hypermarkets   china - june 2013(1)
Supermarkets and hypermarkets china - june 2013(1)QYResearchReports
 
Household cleaning equipment uk - june 2013
Household cleaning equipment   uk - june 2013Household cleaning equipment   uk - june 2013
Household cleaning equipment uk - june 2013QYResearchReports
 
Drinking in the home uk - june 2013
Drinking in the home   uk - june 2013Drinking in the home   uk - june 2013
Drinking in the home uk - june 2013QYResearchReports
 
Mobile VAS Markets Available on Researchmoz.us
Mobile VAS Markets Available on Researchmoz.usMobile VAS Markets Available on Researchmoz.us
Mobile VAS Markets Available on Researchmoz.usQYResearchReports
 
Successfully Accessing Medical Equipment Markets in CIVETS Available on Rese...
Successfully Accessing Medical Equipment Markets in CIVETS  Available on Rese...Successfully Accessing Medical Equipment Markets in CIVETS  Available on Rese...
Successfully Accessing Medical Equipment Markets in CIVETS Available on Rese...QYResearchReports
 
New Cote d'Ivoire Insurance Industry
New Cote d'Ivoire Insurance IndustryNew Cote d'Ivoire Insurance Industry
New Cote d'Ivoire Insurance IndustryQYResearchReports
 

Mais de QYResearchReports (14)

Hotels uk - october 2013
Hotels   uk - october 2013Hotels   uk - october 2013
Hotels uk - october 2013
 
State tourism us - august 2013
State tourism   us - august 2013State tourism   us - august 2013
State tourism us - august 2013
 
Coffee uk - august 2013
Coffee   uk - august 2013Coffee   uk - august 2013
Coffee uk - august 2013
 
Annuities uk - august 2013
Annuities   uk - august 2013Annuities   uk - august 2013
Annuities uk - august 2013
 
Cookware us - july 2013
Cookware   us - july 2013Cookware   us - july 2013
Cookware us - july 2013
 
Underwear uk - june 2013
Underwear   uk - june 2013Underwear   uk - june 2013
Underwear uk - june 2013
 
ResearchMoz - Polymerase chain reaction (pcr) in medical application an analy...
ResearchMoz - Polymerase chain reaction (pcr) in medical application an analy...ResearchMoz - Polymerase chain reaction (pcr) in medical application an analy...
ResearchMoz - Polymerase chain reaction (pcr) in medical application an analy...
 
Supermarkets and hypermarkets china - june 2013(1)
Supermarkets and hypermarkets   china - june 2013(1)Supermarkets and hypermarkets   china - june 2013(1)
Supermarkets and hypermarkets china - june 2013(1)
 
Household cleaning equipment uk - june 2013
Household cleaning equipment   uk - june 2013Household cleaning equipment   uk - june 2013
Household cleaning equipment uk - june 2013
 
Drinking in the home uk - june 2013
Drinking in the home   uk - june 2013Drinking in the home   uk - june 2013
Drinking in the home uk - june 2013
 
Norway Gas Markets, 2013
Norway Gas Markets, 2013Norway Gas Markets, 2013
Norway Gas Markets, 2013
 
Mobile VAS Markets Available on Researchmoz.us
Mobile VAS Markets Available on Researchmoz.usMobile VAS Markets Available on Researchmoz.us
Mobile VAS Markets Available on Researchmoz.us
 
Successfully Accessing Medical Equipment Markets in CIVETS Available on Rese...
Successfully Accessing Medical Equipment Markets in CIVETS  Available on Rese...Successfully Accessing Medical Equipment Markets in CIVETS  Available on Rese...
Successfully Accessing Medical Equipment Markets in CIVETS Available on Rese...
 
New Cote d'Ivoire Insurance Industry
New Cote d'Ivoire Insurance IndustryNew Cote d'Ivoire Insurance Industry
New Cote d'Ivoire Insurance Industry
 

Último

AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfAMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfJohnCarloValencia4
 
MoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor PresentationMoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor Presentationbaron83
 
Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyHanna Klim
 
Slicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinSlicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinAnton Skornyakov
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access
 
Introduction to The overview of GAAP LO 1-5.pptx
Introduction to The overview of GAAP LO 1-5.pptxIntroduction to The overview of GAAP LO 1-5.pptx
Introduction to The overview of GAAP LO 1-5.pptxJemalSeid25
 
Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Winbusinessin
 
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptxHELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptxHelene Heckrotte
 
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...Brian Solis
 
Cracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptxCracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptxWorkforce Group
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessAPCO
 
Project Brief & Information Architecture Report
Project Brief & Information Architecture ReportProject Brief & Information Architecture Report
Project Brief & Information Architecture Reportamberjiles31
 
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003believeminhh
 
Lecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toLecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toumarfarooquejamali32
 
Plano de marketing- inglês em formato ppt
Plano de marketing- inglês  em formato pptPlano de marketing- inglês  em formato ppt
Plano de marketing- inglês em formato pptElizangelaSoaresdaCo
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access
 
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfChicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfSourav Sikder
 
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBBPMedia1
 
PDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdfPDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdfHajeJanKamps
 

Último (20)

AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfAMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
 
MoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor PresentationMoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor Presentation
 
Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agency
 
Slicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinSlicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup Berlin
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024
 
Introduction to The overview of GAAP LO 1-5.pptx
Introduction to The overview of GAAP LO 1-5.pptxIntroduction to The overview of GAAP LO 1-5.pptx
Introduction to The overview of GAAP LO 1-5.pptx
 
Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024
 
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptxHELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
 
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
 
Cracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptxCracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptx
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
 
Project Brief & Information Architecture Report
Project Brief & Information Architecture ReportProject Brief & Information Architecture Report
Project Brief & Information Architecture Report
 
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003
 
Investment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV IndustriesInvestment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV Industries
 
Lecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toLecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb to
 
Plano de marketing- inglês em formato ppt
Plano de marketing- inglês  em formato pptPlano de marketing- inglês  em formato ppt
Plano de marketing- inglês em formato ppt
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024
 
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfChicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
 
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
 
PDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdfPDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdf
 

Researchmoz | GlycoMar Limited - Product Pipeline Review - 2014

  • 1. GlycoMar Limited - Product Pipeline Review - 2014 GlycoMar Limited - Product Pipeline Review - 2014 Summary Global Markets Directs, GlycoMar Limited - Product Pipeline Review - 2014, provides an overview of the GlycoMar Limiteds pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of GlycoMar Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of GlycoMar Limited including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of GlycoMar Limiteds human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the GlycoMar Limiteds pipeline products Reasons to buy - Evaluate GlycoMar Limiteds strategic position with total access to detailed information on its product pipeline - Assess the growth potential of GlycoMar Limited in its therapy areas of focus - Identify new drug targets and therapeutic classes in the GlycoMar Limiteds R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of GlycoMar Limited and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of GlycoMar Limited - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of GlycoMar Limited and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 4 glycomar Limited Snapshot 5 glycomar Limited Overview 5 key Information 5 key Facts 5 glycomar Limited - Research And Development Overview 6 key Therapeutic Areas 6 glycomar Limited - Pipeline Review 9 pipeline Products By Stage Of Development 9 pipeline Products - Monotherapy 10 pipeline Products - Partnered Products 11 partnered Products/combination Treatment Modalities 12 GlycoMar Limited - Product Pipeline Review - 2014
  • 2. glycomar Limited - Pipeline Products Glance 13 glycomar Limited - Early Stage Pipeline Products 13 preclinical Products/combination Treatment Modalities 13 discovery Products/combination Treatment Modalities 14 glycomar Limited - Drug Profiles 15 gly-145 15 product Description 15 mechanism Of Action 15 r&d Progress 15 gly-2028 16 product Description 16 mechanism Of Action 16 r&d Progress 16 gly-079 17 product Description 17 mechanism Of Action 17 r&d Progress 17 gly-198 18 product Description 18 mechanism Of Action 18 r&d Progress 18 glyk-5006 19 product Description 19 mechanism Of Action 19 r&d Progress 19 inflammatory Bowel Disease Program 20 product Description 20 mechanism Of Action 20 r&d Progress 20 glycomar Limited - Pipeline Analysis 21 glycomar Limited - Pipeline Products By Target 21 glycomar Limited - Pipeline Products By Route Of Administration 22 glycomar Limited - Pipeline Products By Molecule Type 23 glycomar Limited - Pipeline Products By Mechanism Of Action 24 glycomar Limited - Locations And Subsidiaries 25 head Office 25 appendix 26 methodology 26 coverage 26 secondary Research 26 primary Research 26 expert Panel Validation 26 contact Us 27 disclaimer 27 list Of Tables glycomar Limited, Key Information 5 glycomar Limited, Key Facts 5 glycomar Limited - Pipeline By Indication, 2014 8 glycomar Limited - Pipeline By Stage Of Development, 2014 9 glycomar Limited - Monotherapy Products In Pipeline, 2014 10 glycomar Limited - Partnered Products In Pipeline, 2014 11 glycomar Limited - Partnered Products/ Combination Treatment Modalities, 2014 12 glycomar Limited - Preclinical, 2014 13 glycomar Limited - Discovery, 2014 14 glycomar Limited - Pipeline By Target, 2014 21 glycomar Limited - Pipeline By Route Of Administration, 2014 22 glycomar Limited - Pipeline By Molecule Type, 2014 23 glycomar Limited - Pipeline Products By Mechanism Of Action, 2014 24 list Of Figures glycomar Limited - Pipeline By Top 10 Indication, 2014 7 glycomar Limited - Pipeline By Stage Of Development, 2014 9 glycomar Limited - Monotherapy Products In Pipeline, 2014 10 glycomar Limited - Pipeline By Top 10 Route Of Administration, 2014 22 glycomar Limited - Pipeline By Top 10 Molecule Type, 2014 23 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your GlycoMar Limited - Product Pipeline Review - 2014
  • 3. research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ GlycoMar Limited - Product Pipeline Review - 2014